AI Verdict
NIQ has stronger fundamentals based on our AI analysis.
NIQ vs NIKA Fundamental Comparison
| Metric | NIQ | NIKA |
|---|---|---|
| Revenue | $4.2B | $0.0 |
| Net Income | $-353.3M | $-76,398.0 |
| Net Margin | -8.4% | N/A |
| ROE | -35.7% | N/A |
| ROA | -5.2% | -363.9% |
| Current Ratio | 1.03x | 0.07x |
| Debt/Equity | 3.54x | N/A |
| EPS | $-1.32 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NIQ vs NIKA: Frequently Asked Questions
Is NIQ or NIKA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NIQ has stronger fundamentals. NIQ is rated SELL (75% confidence) while NIKA is rated STRONG SELL (98% confidence). This is not investment advice.
How does NIQ compare to NIKA fundamentally?
NIQ Global Intelligence plc has ROE of -35.7% vs NIKA PHARMACEUTICALS, INC's N/A. Net margins are -8.4% vs N/A respectively.
Which stock pays higher dividends, NIQ or NIKA?
NIQ has a dividend yield of N/A or no dividend while NIKA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NIQ or NIKA for long term?
For long-term investing, consider that NIQ has SELL rating with 75% confidence, while NIKA has STRONG SELL rating with 98% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NIQ vs NIKA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NIQ vs NIKA, the AI consensus favors NIQ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.